From the Kaplan–Meier analysis, ccRCC patients with a higher DLK2 level had a significantly shorter overall survival (*** p < 0.001) (Figure 4A), but the DLK2 level in ccRCC tissues did not significantly affect disease-free survival (Figure 4B). This evidence concerns the gene DLK2 and nonpapillary renal cell carcinoma.